skip to Global Navigation Bar
skip to main content
HOME
CONTACT US
SITEMAP
KOREAN
Global Business
Introduction
Strategy
Manufacturing
Contact Us
R&D
Introduction
Global R&D Centers
R&D Organization
Pipeline
CDMO
Introduction
Manufacturing Sites
Business Model
Service Range
Products
Global Brand
Products Search
In-License
Introduction
Strategy
No.1 Position
Core-Competency
Licensed Products
Partnership
Investors
Management information
Financial information
Stock condition
IR information
About Us
Company Profile
CEO Message
Recruitment
Press Release
Company Profile
CEO Message
Recruitment
Press Release
News
PR Video
Home > About Us > Press Release >
News
뉴스
No
Subject
Data
220
Daewoong Pharmaceuticals presents result of phase 3 clinical trial on Supect at The Korean Society of Hematology
2016-05-31
219
Daewoong Pharmaceuticals receives Prime Minister Commendation as an ‘Outstanding Company in Fair Gender Employment’
2016-05-26
218
Daewoong Bio ‘UDCA’ passes EDQM (European Directorate for the Quality of Medicines & Healthcare) inspection
2016-05-26
217
Daewoong Pharmaceuticals invites public officials in drug safety management from 11 countries to its Hyangnam Plant
2016-05-26
216
Daewoong Pharmaceuticals’ Zemiglo increases quarterly sales by twofold compared to last year
2016-05-26
215
Daewoong Pharmaceuticals proves fatigue recovery effect of Ursa through clinical trial
2016-04-18
214
Daewoong Pharmaceuticals announces US clinical trial result on Nabota at Dubai Derma and spurs exportation
2016-04-15
213
Daewoong Pharmaceuticals and AstraZeneca Korea jointly sell ‘Cresto’, treatment for hyperlipidemia
2016-04-11
212
Daewoong Pharmaceuticals announces the result of phase 3 clinical trial in US on Nabota
2016-04-08
211
Daewoong Pharmaceuticals signs export contract and MOU with Taiwanese and Malaysian pharmaceutical companies
2016-04-06
1
/
2
/
3
/
4
/
5
/
6
/
7
/
8
/
9
/
10
/
News Search
subject
content
Home > About Us > Press Release > News
Home > About Us > Press Release > News